1.
F Cervantes, JC Hernandez-Boluda, JL Steegmann, E Conde, A Alvarez-Larran, J Lopez-Jimenez, S Osorio, L Villalon, M Camos, J Garcia-Conde, J Odriozola. Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients. haematol [Internet]. 2003Oct.1 [cited 2024Nov.22];88(10):1117-22. Available from: https://haematologica.org/article/view/2872